Home▸AI/ML SaMD Regulatory Pathway▸FDA AI/ML SaMD Predetermined Change Control Plan Simulator

📋 FDA AI/ML SaMD Predetermined Change Control Plan Simulator

This simulation allows users to explore and understand the predetermined change control plan (PCCP) for adaptive medical devices approved by FDA or EMA, focusing on the specific requirements and processes involved.

AI/ML SaMD Regulatory Pathway2DModerate60 FPS
samd-predetermined-change-control-simulator ↗ Open standalone

Filing the Device Together With Its Change Plan

The initial submission bundles the locked model with a plan.

  • 3: PCCP components (types, protocol, impact assessment)
  • Periodic retrain: Typical change type (scheduled data refresh)
  • 510(k) / De Novo / PMA: Submission pathway (device-dependent)
  • Yes: Boundary defined at filing (pre-specified, not ad hoc)

What a PCCP actually specifies

Short placeholder covering anticipated modification types and their limits.

FDA Authorizes Device and Boundary Together

Reviewers evaluate the model and its future-change envelope as one unit.

  • Device + PCCP: Review scope (single authorization event)
  • Corridor: Boundary output (pre-agreed performance envelope)
  • Locked: Modification protocol (defines retrain method/data)
  • Required: Impact assessment (benefit-risk of allowed changes)

Why the boundary is locked at this stage

Short placeholder on how the corridor becomes the controlling envelope.

Retraining Within the Pre-Authorized Envelope

The manufacturer proposes a model change sized by real-world data drift.

  • New training data: Trigger (periodic or performance-driven)
  • Retrain / recalibrate: Change types (per locked protocol)
  • Small → major: Magnitude range (tweak to architecture change)
  • Manufacturer-led: Governance (within PCCP protocol)

Sizing an update against the envelope

Short placeholder on how proposed magnitude compares to the corridor.

Checking Each Update Against Pre-Set Criteria

Performance metrics are re-verified before any update reaches patients.

  • Pre-specified criteria: Verification basis (set during authorization)
  • No, if within bounds: New submission needed (core PCCP benefit)
  • Update report: Documentation (evidence of bound compliance)
  • Full submission: Failure path (if criteria not met)

Pass/fail at the verification gate

Short placeholder describing the in-bounds versus out-of-bounds check.

Agile Iteration Inside a Controlled Envelope

PCCP enables fast updates while keeping every change inside agreed limits.

  • Deploy: Within bounds (no new full submission)
  • Resubmit: Exceeds bounds (new full regulatory review)
  • Agile + controlled: Net effect (speed without open-ended risk)
  • New PCCP needed: Boundary revision (to expand scope later)

Why the envelope matters more than any single update

Short placeholder on sustained control across many future updates.

Short placeholder: the corridor, not any one update, is the real control.
⚙ Under the hood

This simulation allows users to explore and understand the predetermined change control plan (PCCP) for adaptive medical devices approved by FDA or EMA, focusing on the specific requirements and processes involved.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install

What did you find?

Add reproduction steps (optional)